CI

At a glance

ClinicalIndex Comparison Record
Phase 2Active· 111 enrolled
Drug / intervention
Electroacupuncture Therapy +4 moreprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02754752
NCT02754752Phase 2Active

Randomized-Controlled Trial of Acupuncture for Chronic Pain After Breast Cancer Treatment

M.D. Anderson Cancer Center·interventional·Posted Apr 28, 2016·Updated Apr 15, 2026

In Brief

A Phase 2 clinical trial evaluating Electroacupuncture Therapy, Laboratory Biomarker Analysis, and 2 other interventions for Stage I Breast Cancer AJCC v7 and 9 related conditions. Active but no longer recruiting, targeting 111 participants across 1 site.

Detailed Summary

This randomized phase II trial studies how well electroacupuncture therapy works in reducing chronic pain in patients following surgery for stage I-III breast cancer. Electroacupuncture therapy is a type of complementary integrative medicine in which pulses of weak electrical current are sent through very thin, solid, sterile, stainless steel needles into certain points in the skin. Electroacupuncture therapy may help to lower pain and other surgery-related symptoms.

Study Details

Timeline

Phase 2Active
20172018201920202021202220232024202520262027
First PostedApr 28, 2016
Enrollment StartSep 13, 2016
Primary CompletionDec 31, 2026
TodayJul 1, 2026
Enrollment to primary: 10.3 yearsPosted 10.2 years agoPrimary completion in 6 months

Interventions

Electroacupuncture Therapyprocedure

Undergo electroacupuncture therapy

Electroacupuncture Therapyprocedure

Undergo modified electroacupuncture therapy

Laboratory Biomarker Analysisother

Correlative studies

Quality-of-Life Assessmentother

Ancillary studies

Questionnaire Administrationother

Ancillary studies